TY - GEN N2 - Contributing to proteomic diversity, alternative splicing of pre-mRNA is widespread in the human transcriptome and can greatly influence regulation of both normal and disease-related cellular phenotypes. Similar to gene expression, alternative splicing does not occur independently, but in a coordinated fashion throughout the transcriptome in order to maintain proper cellular function. Gene co-expression networks have been widely used as an approach to elucidate coordinated regulatory patterns of gene transcription. Studies have shown that genome-wide expression can occur in the form of network modules consisting of highly co-expressed genes operating within specific cellular pathways. Such modules are often well-preserved across similar biological systems and associated with various phenotypes. Here we demonstrate a framework for de novo network inference of co-splicing in the form of modules consisting of complex alternative splicing variants. DO - 10.6083/5h73pw81c DO - DOI AB - Contributing to proteomic diversity, alternative splicing of pre-mRNA is widespread in the human transcriptome and can greatly influence regulation of both normal and disease-related cellular phenotypes. Similar to gene expression, alternative splicing does not occur independently, but in a coordinated fashion throughout the transcriptome in order to maintain proper cellular function. Gene co-expression networks have been widely used as an approach to elucidate coordinated regulatory patterns of gene transcription. Studies have shown that genome-wide expression can occur in the form of network modules consisting of highly co-expressed genes operating within specific cellular pathways. Such modules are often well-preserved across similar biological systems and associated with various phenotypes. Here we demonstrate a framework for de novo network inference of co-splicing in the form of modules consisting of complex alternative splicing variants. AD - Oregon Health and Science University T1 - Network-based alternative splicing signatures of drug response in AML DA - 2020 AU - Egger, Julian L1 - https://digitalcollections.ohsu.edu/record/8743/files/Egger.Julian.2020.pdf PB - Oregon Health and Science University PB - Oregon Health and Science University PY - 2020 ID - 8743 L4 - https://digitalcollections.ohsu.edu/record/8743/files/Egger.Julian.2020.pdf KW - Genomics KW - Alternative Splicing KW - acute myeloid leukemia KW - rna-sequencing KW - bioinformatics TI - Network-based alternative splicing signatures of drug response in AML Y1 - 2020 L2 - https://digitalcollections.ohsu.edu/record/8743/files/Egger.Julian.2020.pdf LK - https://digitalcollections.ohsu.edu/record/8743/files/Egger.Julian.2020.pdf UR - https://digitalcollections.ohsu.edu/record/8743/files/Egger.Julian.2020.pdf ER -